---
title: "The synthetic biology concept fluctuates and rises sharply, Tuoxin Pharmaceutical and Xinhua Pharm hit the limit up"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240510584.md"
description: "The synthetic biology concept has fluctuated and risen sharply, with Tuoxin Pharmaceutical hitting the daily limit, Xinhua Pharm previously hitting the daily limit, and companies like Furuida, Rundu Co., Ltd., Jindawei, and Ruipu Biotech seeing significant gains"
datetime: "2025-05-16T06:35:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240510584.md)
  - [en](https://longbridge.com/en/news/240510584.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240510584.md)
generator: "portal-rs"
---

# The synthetic biology concept fluctuates and rises sharply, Tuoxin Pharmaceutical and Xinhua Pharm hit the limit up

The synthetic biology concept has fluctuated and risen sharply, with Tuoxin Pharmaceutical hitting the daily limit, Xinhua Pharm previously hitting the daily limit, and companies like Furuida, Rundu Co., Ltd., Jindawei, and Ruipu Biotech seeing significant gains

### Related Stocks

- [301089.CN](https://longbridge.com/en/quote/301089.CN.md)
- [000756.CN](https://longbridge.com/en/quote/000756.CN.md)
- [00719.HK](https://longbridge.com/en/quote/00719.HK.md)
- [300119.CN](https://longbridge.com/en/quote/300119.CN.md)
- [600223.CN](https://longbridge.com/en/quote/600223.CN.md)
- [002923.CN](https://longbridge.com/en/quote/002923.CN.md)
- [002626.CN](https://longbridge.com/en/quote/002626.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [BMS Holdings Q4 FY2026 PAT Rises 106.5% QoQ to RM5.04 Million](https://longbridge.com/en/news/296892849.md)
- [08:36 ETUltimate Men's HQ Launches Private Product-Match Education Experience](https://longbridge.com/en/news/296789283.md)
- [As WCI 2026 Turns to Non-Surgical, Opioid-Sparing Care for Injured Workers, ZetrOZ Brings the Outcomes Data to Booth #701](https://longbridge.com/en/news/296810404.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**